Krystal Biotech

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$107,105
$97,800
$96,042
$88,183
Gross Profit
96,188
92,137
88,877
83,155
EBITDA
39,609
49,576
40,850
37,811
EBIT
37,844
47,967
39,307
36,177
Net Income
51,400
79,365
38,333
35,733
Net Change In Cash
107,105
97,800
96,042
88,183
Free Cash Flow
75,369
37,955
50,825
24,765
Cash
496,304
392,604
353,829
308,770
Basic Shares
29,951
29,833
29,749
29,871

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$389,130
$290,515
$50,699
$0
Gross Profit
360,357
270,454
47,605
-4,055
EBITDA
167,846
109,909
-91,316
-116,811
EBIT
161,295
103,195
-97,227
-120,196
Net Income
204,831
89,159
10,932
-139,975
Net Change In Cash
389,130
290,515
50,699
0
Free Cash Flow
188,914
119,182
-100,603
-153,548
Cash
496,304
344,865
358,328
161,900
Basic Shares
29,951
29,740
27,752
25,492

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$1.70
2025-09-30
$2.66
2025-06-30
$1.29